Search by Drug Name or NDC
NDC 82009-0021-05 Clopidogrel bisulfate 75 mg/1 Details
Clopidogrel bisulfate 75 mg/1
Clopidogrel bisulfate is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Quallent Pharmaceuticals Health LLC. The primary component is CLOPIDOGREL BISULFATE.
Product Information
| NDC | 82009-0021 |
|---|---|
| Product ID | 82009-021_599b792d-2fa0-0fda-239d-ad545fc452c0 |
| Associated GPIs | |
| GCN Sequence Number | 038164 |
| GCN Sequence Number Description | clopidogrel bisulfate TABLET 75 MG ORAL |
| HIC3 | M9P |
| HIC3 Description | PLATELET AGGREGATION INHIBITORS |
| GCN | 96010 |
| HICL Sequence Number | 017539 |
| HICL Sequence Number Description | CLOPIDOGREL BISULFATE |
| Brand/Generic | Generic |
| Proprietary Name | Clopidogrel bisulfate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Clopidogrel bisulfate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 75 |
| Active Ingredient Units | mg/1 |
| Substance Name | CLOPIDOGREL BISULFATE |
| Labeler Name | Quallent Pharmaceuticals Health LLC |
| Pharmaceutical Class | Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA076273 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 82009-0021-05 (82009002105)
| NDC Package Code | 82009-021-05 |
|---|---|
| Billing NDC | 82009002105 |
| Package | 500 TABLET, FILM COATED in 1 BOTTLE (82009-021-05) |
| Marketing Start Date | 2022-11-15 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.064 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | CLOPIDOGREL 75 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis